Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2023 / N 2

Современные подходы к фармакотерапии дивертикулярной болезни
Г.Б. Селиванова, Н.Г. Потешкина

Список литературы/References

1. Tursi A. Diverticulosis today: unfashionable and still under-researched. Therapeutic Advances in Gastroenterology. 2016;9(2):213-228. DOI: 10.1177/1756283X15621228
2. Schieffer KM, Kline BP, Yochum GS, Koltun WA. Pathophysiology of diverticular disease. Expert Review of Gastroenterology & Hepatology. 2018;12(7):683-692. DOI: 10.1080/17474124.2018.1481746
3. Tursi A, Papa A, Danese S. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. Alimentary Pharmacology & Therapeutics. 2015;42(6):664-684. DOI: 10.1111/apt.13322
4. Ивашкин В.Т., Шелыгин Ю.А., Ачкасов С.И., Васильев С.В., Григорьев Е.Г., Дудка В.В., Жуков Б.Н., Карпухин О.Ю., Кузьминов А.М., Куликовский В.Ф., Лапина Т.Л., Лахин А.В., Маев И.В., Москалев А.И., Муравьев А.В., Половинкин В.В., Полуэктова Е.А., Стойко Ю.М., Тимербулатов В.М., Трухманов А.С., Фролов С.А., Чибисов Г.И., Шифрин О.С., Шептулин А.А., Халиф И.Л., Эфрон А.Г., Яновой В.В. Рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых больных дивертикулярной болезнью ободочной кишки. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;1:65-80. [Ivashkin VT, Shelygin YuA, Achkasov SI, Vasilyev SV, Grigoryev EG, Dudka VV, Zhukov BN, Karpukhin OYu, Kuzminov AM, Kulikovskiy VF, Lapina TL, Lakhin AV, Mayev IV, Moskalev AI, Muravyev AV, Polovinkin VV, Poluektova EA, Stoiko YuM, Timerbulatov VM, Trukhmanov AS, Frolov SA, Chibisov GI, Shifrin OS, Sheptulin AA, Khalif IL, Efron AG, Yanov VV. Diagnostics and treatment of diverticular disease of the colon: guidelines of the Russian gastroenterological Association and Russian Association of Coloproctology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;1:65-80 (In Russ.).]
5. Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A, Danese S. Colonic diverticular disease. Nature Reviews. Disease Primers. 2020;6(1):20. DOI: 10.1038/s41572-020-0153-5
6. Lanas A, Abad-Baroja D, Lanas-Gimeno A. Progress and challenges in the management of diverticular disease: which treatment? Therapeutic Advances in Gastroenterology. 2018;11:175628481878905. DOI: 10.1177/1756284818789055
7. Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, Jensen ET, Lund JL, Pasricha S, Runge T, Schmidt M, Shaheen NJ, Sandler RS. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(7):1731-1741.e3. DOI: 10.1053/j.gastro.2015.08.045
8. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009;136(3):741-754. DOI: 10.1053/j.gastro.2009.01.015
9. Yamamichi N, Shimamoto T, Takahashi Y, Sakaguchi Y, Kakimoto H, Matsuda R, Kataoka Y, Saito I, Tsuji Y, Yakabi S, Takeuchi C, Minatsuki C, Niimi K, Asada-Hirayama I, Nakayama C, Ono S, Kodashima S, Yamaguchi D, Fujishiro M, Yamaji Y, Wada R, Mitsushima T, Koike K. Trend and risk factors of diverticulosis in Japan: age, gender, and lifestyle/metabolic-related factors may cooperatively affect on the colorectal diverticula formation. PLoS One. 2015;10(4):e0123688. DOI: 10.1371/journal.pone.0123688
10. Song JH, Kim YS, Lee JH, Ok KS, Ryu SH, Lee JH, Moon JS. Clinical characteristics of colonic diverticulosis in Korea: a prospective study. The Korean Journal of Internal Medicine. 2010;25(2):140-146. DOI: 10.3904/kjim.2010.25.2.140
11. Shahedi K, Fuller G, Bolus R, Cohen E, Vu M, Shah R, Agarwal N, Kaneshiro M, Atia M, Sheen V, Kurzbard N, van Oijen MG, Yen L, Hodgkins P, Erder MH, Spiegel B. Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clinical Gastroenterology and Hepatology. 2013;11(12):1609-1613. DOI: 10.1016/j.cgh.2013.06.020
12. Faucheron JL, Roblin X, Bichard P, Heluwaert F. The prevalence of right-sided colonic diverticulosis and diverticular haemorrhage. Colorectal Disease. 2013;15(5):e266-e270. DOI: 10.1111/codi.12137
13. Gralnek IM, Neeman Z, Strate LL. Acute lower gastrointestinal bleeding. New England Journal of Medicine. 2017;376(11):1054-1063. DOI: 10.1056/NEJMcp1603455
14. Binda GA, Mataloni F, Bruzzone M, Carabotti M, Cirocchi R, Nascimbeni R, Gambassi G, Amato A, Vettoretto N, Pinnarelli L, Cuomo R, Annibale B. Trends in hospital admission for acute diverticulitis in Italy from 2008 to 2015. Techniques in Coloproctology. 2018;22(8):597-604. DOI: 10.1007/s10151-018-1840-z
15. Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology. 2019;156(5):1282-1298.e1. DOI: 10.1053/j.gastro.2018.12.033
16. Wess L, Eastwood MA, Edwards CA, Busuttil A, Miller A. Collagen alteration in an animal model of colonic diverticulosis. Gut. 1996;38(5):701-706. DOI: 10.1136/gut.38.5.701
17. Wedel T, Barrenschee M, Lange C, Cossais F., Böttner M. Morphologic basis for developing diverticular disease, diverticulitis, and diverticular bleeding. Viszeralmedizin. 2015;31(2):76-82. DOI: 10.1159/000381431
18. Humes DJ, Simpson J, Smith J, Sutton P, Zaitoun A, Bush D, Bennett A, Scholefield JH, Spiller RC. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterology & Motility. 2012;24(4):318-e163. DOI: 10.1111/j.1365-2982.2011.01863.x
19. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. The Journal of Physiology. 2009;587(Pt. 17):4153-4158. DOI: 10.1113/jphysiol.2009.174136
20. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332-1345. DOI: 10.1016/j.cell.2016.05.041
21. Hullar MA, Sandstrom R, Lampe JW, Strate LL. The fecal microbiome differentiates patients with a history of diverticulitis vs those with uncomplicated diverticulosis. Gastroenterology. 2017;152:S624. DOI: 10.1016/S0016-5085(17)32217-5
22. Rosemar A, Ivarsson ML, Börjesson L, Holmdahl L. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scandinavian Journal of Gastroenterology. 2007;42(2):215-220. DOI: 10.1080/00365520600960104
23. Böttner M, Barrenschee M, Hellwig I, Harde J, Egberts JH, Becker T, Zorenkov D, Schäfer KH, Wedel T. The GDNF system is altered in diverticular disease – implications for pathogenesis. PLoS One. 2013;8(6):e66290. DOI: 10.1371/journal.pone.0066290
24. Bassotti G, Battaglia E, Bellone G, Dughera L, Fisogni S, Zambelli C, Morelli A, Mioli P, Emanuelli G, Villanacci V. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. Journal of Clinical Pathology. 2005;58(9):973-977. DOI: 10.1136/jcp.2005.026112
25. Clemens CH, Samsom M, Roelofs J, van Berge Henegouwen GP, Smout AJ. Colorectal visceral perception in diverticular disease. Gut. 2004;53:717-722. DOI: 10.1136/gut.2003.018093
26. Hjern F, Johansson C, Mellgren A, Baxter NN, Hjern A. Diverticular disease and migration – the influence of acculturation to a Western lifestyle on diverticular disease. Alimentary Pharmacology and Therapeutics. 2006;23(6):797-805. DOI: 10.1111/j.1365-2036.2006.02805.x
27. Stagi S, Lapi E, Chiarelli F, de Martino M. Incidence of diverticular disease and complicated diverticular disease in young patients with Williams syndrome. Pediatric Surgery International 2010;26(9):943-944. DOI: 10.1007/s00383-010-2666-6
28. Granlund J, Svensson T, Olén O, Hjern F, Pedersen NL, Magnusson PK, Schmidt PT. The genetic influence on diverticular disease – a twin study. Alimentary Pharmacology & Therapeutics. 2012;35(9):1103-1107. DOI: 10.1111/j.1365-2036.2012.05069.x
29. Kruis W, Germer CT, Leifeld L; German Society for Gastroenterology, Digestive and Metabolic Diseases and The German Society for General and Visceral Surgery. Diverticular disease: guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases and the German Society for General and Visceral Surgery. Digestion. 2014;90(3):190-207. DOI: 10.1159/000367625
30. Bor R, Fábián A, Szepes Z. Role of ultrasound in colorectal diseases. World Journal of Gastroenterology. 2016;22(43):9477-9487. DOI: 10.3748/wjg.v22.i43.9477
31. Kechagias A, Sofianidis A, Zografos G, Leandros E, Alexakis N, Dervenis C. Index C-reactive protein predicts increased severity in acute sigmoid diverticulitis. Therapeutics and Clinical Risk Management. 2018;14:1847-1853. DOI: 10.2147/TCRM.S160113
32. Tursi A. Biomarkers in diverticular diseases of the colon. Digestive Diseases (Basel, Switzerland). 2012;30(1):12-18. DOI: 10.1159/000335695
33. Tursi A. A critical appraisal of advances in the diagnosis of diverticular disease. Expert Review of Gastroenterology & Hepatology. 2018;12(8):791-796. DOI: 10.1080/17474124.2018.1487288
34. Corazza GR, Di Stefano M, Scarpignato C. Treatment of functional bowel disorders: is there room for antibiotics? Digestion. 2006;73(Suppl. 1):38-46. DOI: 10.1159/000089778
35. Frieri G, Pimpo MT, Scarpignato C. Management of colonic diverticular disease. Digestion. 2006;73(Suppl. 1):58-66. DOI: 10.1159/000089780
36. Ponziani FR, Zocco MA, D’Aversa F, Pompili M, Gasbarrini A. Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation. World Journal of Gastroenterology. 2017;23(25):4491-4499. DOI: 10.3748/wjg.v23.i25.4491
37. Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics. 2017;45(5):604-616. DOI: 10.1111/apt.13928
38. Viscomi GC, Barbanti M, Grepioni F, Polito M, Confortini D, Rosini G, Righi P, Cannata V, Braga D. Crystal forms of rifaximin and their effect on pharmaceutical properties. CrystEngComm. 2008;10(8):1074-1081. DOI: 10.1039/B717887E
39. Dupont HL. Review article: the antimicrobial effects of rifaximin on the gut microbiota. Alimentary Pharmacology & Therapeutics. 2016;43(Suppl. 1):3-10. DOI: 10.1111/apt.13434
40. Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. International Journal of Clinical Pharmacology Research. 1994;14(2):51-56. PMID: 7836025
41. Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World Journal of Gastroenterology. 2016;22(29):6638-6651. DOI: 10.3748/wjg.v22.i29.6638
42. Umezawa H, Mizuno S, Yamazaki H, Nitta K. Inhibition of DNA-dependent RNA synthesis by rifamycins. The Journal of Antibiotics. 1968;21(3):234-236. DOI: 10.7164/antibiotics.21.234
43. Adachi JA, Dupont HL. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clinical Infectious Diseases. 2006;42(4):541-547. DOI: 10.1086/499950
44. Painter NS, Burkitt DP. Diverticular disease of the colon: a deficiency disease of Western civilization. British Medical Journal. 1971;2:450-454. DOI: 10.1136/bmj.2.5759.450
45. Ponziani FR, Pecere S, Lopetuso L, Scaldaferri F, Cammarota G, Gasbarrini A. Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation. Expert Opinion on Drug Safety. 2016;15(7):983-991. DOI: 10.1080/14740338.2016.1186639
46. Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P. Repeat rifaximin for irritable bowel syndrome: no clinically significant changes in stool microbial antibiotic sensitivity. Digestive Diseases and Sciences. 2017;62(9):2455-2463. DOI: 10.1007/s10620-017-4598-7
47. Kim MS, Morales W, Hani AA, Kim S, Kim G, Weitsman S, Chang C, Pimentel M. The effect of rifaximin on gut flora and staphylococcus resistance. Digestive Diseases and Sciences. 2013;58(6):1676-1682. DOI: 10.1007/s10620-013-2675-0
48. Calanni F, Renzulli C, Barbanti M, Viscomi GC. Rifaximin: beyond the traditional antibiotic activity. The Journal of Antibiotics. 2014;67(9):667-670. DOI: 10.1038/ja.2014.106
49. Brown EL, Xue Q, Jiang ZD, Xu Y, DuPont HL. Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles. Antimicrobial Agents and Chemotherapy. 2010;54(1):388-396. DOI: 10.1128/AAC.00691-09
50. Moniuszko A, Rydzewska G. The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Przegla̜d Gastroenterologiczny. 2017;12(2):145-151. DOI: 10.5114/pg.2017.68167
51. Copaci I, Constantinescu G, Mihăilă M, Micu L, Franculescu-Bertea A. Efficacy of rifaximin-A vs dietary fiber on the evolution of uncomplicated colonic diverticular disease. Surgery, Gastroenterology and Oncology. 2019;24(5):233-240. DOI: 10.21614/sgo-24-5-233
52. Di Mario F, Miraglia C, Cambiè G, Violi A, Nouvenne A, Franceschi M, Brandimarte G, Elisei W, Picchio M, Tursi A. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon. Journal of Investigative Medicine. 2019;67(4):767-770. DOI: 10.1136/jim-2018-000901
53. Bianchi M, Festa V, Moretti A, Ciaco A, Mangone M, Tornatore V, Dezi A, Luchetti R, De Pascalis B, Papi C, Koch M. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Alimentary Pharmacology & Therapeutics. 2011;33(8):902-910. DOI: 10.1111/j.1365-2036.2011.04606.x
54. Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Novi M, Sottili S, Vitale G, Cesario V, Serricchio M, Cammarota G, Gasbarrini G, Gasbarrini A. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. The American Journal of Gastroenterology. 2008;103(8):2031-2035. DOI: 10.1111/j.1572-0241.2008.02030.x
55. Hall JF, Roberts PL, Ricciardi R, Read T, Scheirey C, Wald C, Marcello PW, Schoetz DJ. Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Diseases of the Colon & Rectum. 2011;54(3):283-288. DOI: 10.1007/DCR.0b013e3182028576
56. Lanas A, Ponce J, Bignamini A, Mearin F. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Digestive and Liver Disease. 2013;45(2):104-109. DOI: 10.1016/j.dld.2012.09.006
57. Селиванова Г.Б., Потешкина Н.Г., Сванадзе А.М., Рациональная фармакотерапия острых кишечных инфекций в клинической практике. Лечебное дело. 2022;3-4:78-86. [Selivanova GB, Poteshkina NG, Svanadze AM11. Rational pharmacological management of acute intestinal infections in clinical practice. Lechebnoye Delo. 2022;3-4:78-86. (In Russ.).] DOI: 10.24412/2071-5315-2022-12922
58. Barbara G, Cremon C, Barbaro MR, Bellacosa L, Stanghellini V. Treatment of diverticular disease with aminosalicylates: the evidence. Journal of Clinical Gastroenterology. 2016;50(Suppl. 1):S60-S63. DOI: 10.1097/MCG.0000000000000611
59. Scarpignato C, Bertelé A, Tursi A. Probiotics for the treatment of symptomatic uncomplicated diverticular disease: rationale and current evidence. Journal of Clinical Gastroenterology. 2016;50(Suppl. 1):S70-S73. DOI: 10.1097/MCG.0000000000000641
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]